Cancer Family
Solid Neoplasm
CI-CAN-00000052Explore in graph →
Non-malignant1,822 active trials28 evidence items
- NCIt
- C9292
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000052Explore in graph →
Clinical trials
6,088 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04895592 | Radiosurgery Before Surgery for the Treatment of Brain Metastases | completed | Early Phase 1 | 26 | Emory UniversityOTHER | 1 | May 14, 2026 | clinicaltrials |
| NCT07587996 | Exploratory Clinical Study of ¹⁷⁷Lu-CTR-FAPI in Patients With Metastatic Solid Tumors | completed | Early Phase 1 | 12 | Lanzhou University Second HospitalOTHER | 1 | May 14, 2026 | clinicaltrials |
| NCT03445858 |
| Pembrolizumab in Combination With Decitabine and Hypofractionated Index Lesion Radiation in Pediatrics and Young Adults |
| completed |
| Early Phase 1 |
| 22 |
| Children's Hospital Medical Center, CincinnatiOTHER |
| 1 |
| Feb 18, 2026 |
| clinicaltrials |
| NCT07299253 | Preclinical Safety Evaluation and First-in-Human Translational Study of [177Lu]Lu-TEFAPI-06 | completed | Early Phase 1 | 5 | Lanzhou University Second HospitalOTHER | 1 | Dec 23, 2025 | clinicaltrials |
| NCT05908773 | A Microdose Study of TTX-MC138-NODAGA-Cu64 in Subjects With Advanced Solid Tumors | completed | Early Phase 1 | 1 | TransCode TherapeuticsINDUSTRY | 1 | Jan 28, 2025 | clinicaltrials |
| NCT05346692 | Digital Meditation for Postoperative Pain Control After Abdominal Surgery for Cancer | completed | Early Phase 1 | 73 | Emory UniversityOTHER | 1 | Jan 14, 2025 | clinicaltrials |
| NCT04742595 | Viral Specific T Cell Therapy for COVID-19 Related Pneumonia | completed | Early Phase 1 | 32 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 29, 2024 | clinicaltrials |
| NCT04067960 | Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV Cancer | completed | Early Phase 1 | 197 | Mayo ClinicOTHER | 1 | Aug 14, 2024 | clinicaltrials |
| NCT04552418 | Intestinal Microbiome Modification With Resistant Starch in Patients Treated With Dual Immune Checkpoint Inhibitors | completed | Early Phase 1 | 12 | University of Michigan Rogel Cancer CenterOTHER | 1 | Feb 28, 2024 | clinicaltrials |
| NCT06266923 | A Clinical Study of SPH6516 Tablets in the Treatment of Advanced Solid Tumors. | completed | Early Phase 1 | 16 | Shanghai Pharmaceuticals Holding Co., LtdINDUSTRY | 1 | Feb 20, 2024 | clinicaltrials |
| NCT05126927 | A PET Imaging Agent to Assess the Level of Tumor Tissue-infiltrating CD8 + T Cells in Patients With Solid Tumors | completed | Early Phase 1 | 11 | SmartNuclide BiopharmaINDUSTRY | 1 | Apr 12, 2023 | clinicaltrials |
| NCT02013492 | Propranolol Hydrochloride in Treating Patients With Locally Recurrent or Metastatic Solid Tumors That Cannot Be Removed By Surgery | completed | Early Phase 1 | 1 | William CarsonOTHER | 1 | Dec 6, 2022 | clinicaltrials |
| NCT00424242 | Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases | completed | Early Phase 1 | 15 | Northwestern UniversityOTHER | 1 | Sep 8, 2021 | clinicaltrials |
| NCT04046016 | A Study Using Whole-body PET After Oral Microdose of 18F-labeled Liporaxel in Patients With Solid Tumor | completed | Early Phase 1 | 2 | Seoul National University HospitalOTHER | 1 | Aug 6, 2019 | clinicaltrials |
| NCT02646319 | Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations | completed | Early Phase 1 | 2 | Mayo ClinicOTHER | 1 | Jun 6, 2019 | clinicaltrials |
| NCT02285738 | Anti-Platelet and Statin Therapy to Prevent Cancer-Associated Thrombosis | completed | Early Phase 1 | 17 | Case Comprehensive Cancer CenterOTHER | 1 | May 8, 2019 | clinicaltrials |
| NCT00896792 | Nurse Practitioner Hospice Program for Patients With Terminal Metastatic Cancer and Their Families or Caregivers | completed | Early Phase 1 | 26 | Mayo ClinicOTHER | 1 | Oct 9, 2018 | clinicaltrials |
| NCT02157831 | Redosing With CP-870, 893 in Patients With Clinical Benefit After a Single Infusion From A Phase I, Open-Label, Dose-Escalation Study of CP-870,893 in Patients With Solid Tumors | completed | Early Phase 1 | 10 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Aug 17, 2018 | clinicaltrials |
| NCT00816335 | Fludeoxyglucose F 18 PET/CT Imaging in Finding Cancer in Patients Undergoing Surgery for Solid Tumors | completed | Early Phase 1 | 65 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Apr 4, 2016 | clinicaltrials |
| NCT00583063 | Interaction Study of Rapamycin and Sunitinib in Patients With Advanced Cancers | completed | Early Phase 1 | 23 | University of ChicagoOTHER | 1 | Jun 12, 2013 | clinicaltrials |
Data updated 22 days agoSource updated May 14, 2026source: clinicaltrials